Advisory Board Members
| Name | Affiliation |
|---|---|
| S. Kales | Harvard University, SPH |
| M. Kellis | Massachusetts Institute of Technology |
| L. Kranias | University of Cincinnati |
| A. Patrinos | Synthetic Genomics Inc. |
| C. Pothoulakis | University of California Los Angeles |
| G. Stephanopoulos | Massachusetts Institute of Technology |
| C. Stratakis | National Institute of Health |
| M. Tolikas | Wyss Institute (Harvard Medical School) |
| G. Tsokos | Harvard Medical School |
| T. Theoharides | Tufts University |
Advisory Board Members at Large
| Name | Affiliation |
|---|---|
| G D. Behrakis | Leadership 100 |
| R. P. Vagelos | Regeneron Pharmaceuticals |
Advisory Board Members
| Name | Affiliation |
|---|---|
| S. Kales | Harvard University, SPH |
| M. Kellis | Massachusetts Institute of Technology |
| L. Kranias | University of Cincinnati |
| A. Patrinos | Synthetic Genomics Inc. |
| C. Pothoulakis | University of California Los Angeles |
| G. Stephanopoulos | Massachusetts Institute of Technology |
| C. Stratakis | National Institute of Health |
| M. Tolikas | Wyss Institute (Harvard Medical School) |
| G. Tsokos | Harvard Medical School |
| T. Theoharides | Tufts University |
Advisory Board Members at Large
| Name | Affiliation |
|---|---|
| G D. Behrakis | Leadership 100 |
| R. P. Vagelos | Regeneron Pharmaceuticals |